Study of Access Site for Enhancing PCI in STEMI for Seniors (SAFE STEMI for Seniors)
Public ClinicalTrials.gov record NCT02939976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Patients with partially blocked blood vessel(s) in their heart may need a medical procedure called "Percutaneous Coronary Intervention (PCI)" to open the narrowed blood vessel(s). The purpose of this study is to simultaneously address four potential advances in ST-Elevation Myocardial Infarction (STEMI) care for patients at least 65 years old. The investigators are looking to see if these advances can improve the outcome for these patients. 1. Opening the arteries with a Medtronic stent 2. Radial access (from wrist) success with a Medtronic stent 3. Checking the percent of blockage in the diseased artery/arteries using Volcano guide wires. 4. Reduced bleeding and vascular complications with radial arterial access for primary PCI in STEMI.
Study identification
- NCT ID
- NCT02939976
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 427 participants
Conditions and interventions
Conditions
Interventions
- Single Vessel Disease Device
- Multi-vessel Disease, Culprit Vessel Only Procedure
- Multi-vessel Disease, Complete Revascularization Procedure
- Medtronic Resolute family of stents Device
- Volcano based pressure wires Verrata, Verrata Plus and any subsequent marketed Volcano pressure wire technology Device
- Terumo Glidesheath Slender Device
- Terumo TR Band Radial Compression Device Device
Device · Procedure
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2017
- Primary completion
- Jul 18, 2023
- Completion
- Jul 18, 2023
- Last update posted
- Apr 28, 2025
2017 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duke Clinical Research Institute | Durham | North Carolina | 27715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02939976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2025 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02939976 live on ClinicalTrials.gov.